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aBstraCt
introduCtion. The purpose of the study was to evaluate the safety and efficacy of photorefractive keratectomy 
(PRK) combined with corneal collagen crosslinking (CXL) in patients with potential risk of developing postoperative 
ectasia, who were not good candidates for LASIK.
MateriaLs and Methods. Twenty eyes were treated with transepithelial PRK combined with CXL. Patients were 
evaluated preoperatively for best corrected visual acuity (BCVA), refraction, keratometry, topography, and endotheli-
al cell count. All eyes were treated with Amaris 750s Excimer Laser and KXL system for 90 seconds at 30 mW/cm2. 
resuLts. Mean BCVA was improved from 0.0075 ± 0.08 logMAR to 0.025 ± 0.05 logMAR postoperatively. 
Average keratometry reduced from 44.9 ± 1.9 D to 39.8 ± 3.9 D. Mean minimal corneal thickness reduced from 
504 ± 16.7 μm to 405 ± 41 μm. None of the cases developed regression, corneal ectasia, or corneal haze.
ConCLusions. Photorefractive keratectomy combined with high-fluence corneal collagen crosslinking (PRK 
XTRA) appears to be a safe and effective treatment for patients who are not good candidates for LASIK. 
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introduCtion
Corneal ectasia is one of the most severe compli-
cations after refractive surgery, especially LASIK [1]. 
Although it is very rare, there are reports in the lit-
erature of patients who developed iatrogenic ectasia 
after PRK. In such cases, patients develop increas-
ing myopia [2], with or without increasing astig-
matism. Keratometric steepening, with or without 
central and paracentral corneal thinning, can occur 
and there is often loss of uncorrected visual acuity 
(UCVA) and best corrected visual acuity (BCVA).
For these reasons, ophthalmologists should eval-
uate patients according to criteria [3, 4] designed 
specially to avoid potential post-operative ectasia. 
These criteria [2] are: 
• abnormal preoperative topography;
• low residual stromal bed (RSB);
• young age;
• low preoperative corneal thickness;
• high myopia.
A number of treatments [5, 6] to avoid or sta-
bilise corneal ectasia have been described, the most 
recent of them being collagen crosslinking.
The purpose of this study is to evaluate the safety 
and efficacy of transepithelial PRK combined with 
corneal collagen crosslinking (PRK XTRA). The 
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group of patients that underwent PRK XTRA did 
not fit the criteria to proceed to LASIK surgery due 
to low preoperative corneal thickness (< 530 μm), 
RSB < 300 μm, and/or abnormal corneal topogra-
phy. All patients were thoroughly screened by Dr. 
Ioannis Mallias, who then performed the surgeries. 
MateriaLs and Methods
Ten patients (20 eyes) were included in the 
study. They all had myopia and/or myopic astigma-
tism. The mean spherical equivalent of their refrac-
tive error was –5.50 dioptres. All patients were given 
a thorough slit lamp examination. They were also 
subjected to Scheimpflug-generated corneal topog-
raphy (Pentacam HR, Oculus, Germany) and En-
dothelial Cell Count (EM-3000, Tomey, Germany). 
All patients were examined postoperatively by Cor-
neal Optical Coherence Tomography (Spectralis, 
Heidelberg Engineering, Germany). Preoperatively 
we evaluated uncorrected visual acuity, best correct-
ed distance visual acuity (BCVA), and subjective 
refraction with and without the use of cycloplegic 
drops. The inclusion criteria were: no previous oc-
ular surgery, refractive stability for at least one year 
and discontinuation of contact lenses for at least 
one month. The exclusion criteria were: systemic or 
ocular diseases, eyes with herpetic eye disease or his-
tory of corneal dystrophy, epithelial warpage from 
contact lens use, corneal scarring, severe dry eye, 
and glaucoma. All surgeries were performed with 
a Excimer Laser Amaris 750s (Schwind, Germany) 
and KXL System (Avedro, USA). Prior to the op-
eration, all surgical risks were explained to patients 
and informed consent was signed by each of them.
surgiCaL teChnique
In all cases, laser ablation was performed by 
Schwind Amaris 750s using a transepithelial PRK 
module (the excimer laser removed the corneal epi-
thelium). Following the ablation riboflavin (Vibex 
Xtra, 0.22% Riboflavin, Saline, Isotonic, Avedro, 
USA) was instilled onto the cornea for 90 sec-
onds and then rinsed thoroughly. The KXL system 
(Avedro, USA) was then employed to provide UVA 
exposure for 90 seconds at 30 mW/cm2. Finally, 
a soft bandage contact lens was applied for four 
days, until complete corneal re-epithelisation was 
achieved. Patients were prescribed ofloxacin four 
times daily, dexamethasone four times daily, and 
preservative free artificial tears every two hours for 
the first postoperative week. After the first week, 
ofloxacin and dexamethasone were discontinued. 
Loteprednol was prescribed four times daily and was 
slowly tapered over a period of three months. Pre-
servative free artificial tears were continued for the 
first postoperative months as needed. Follow-up ex-
aminations were performed four days, one month, 
six months, one year, and two years after the surgery.
resuLts
The mean age of the patients was 
22.5 ± 3 years. Mean BCVA preoperatively was 
0.0075 ± 0.08 logMAR. Improvement of visual acui-
ty was achieved. Postoperative mean visual acuity was 
0.025 ± 0.05 logMAR. Average cornea keratometry 
was 44.9 ± 1.9 D preoperatively, and it was reduced 
to 39.8 ± 3.9 D postoperatively. Mean minimal cor-
neal thickness evaluated by Scheimpflug topography 
was 504 ± 16 μm preoperatively and 405 ± 41 μm 
12 months after surgery. Specular microscopy was 
performed to evaluate endothelium cells, which did 
not seem to have undergone any changes after sur-
gery. None of the patients had regression of myopia 
or corneal ectasia at mean 2 ± 0.6 years. None of the 
patients developed corneal haze after the surgery. 
In 85% (17 eyes) of treated eyes BCVA remained 
the same. In 10% (2 eyes) of treated eyes, visual 
acuity was improved by one Snellen line and in 5% 
(1 eye) of treated eyes, visual acuity improved by 
2 Snellen lines (Fig. 1).
disCussion
PRK combined with corneal crosslinking is an 
excellent choice for patients with high myopia and 
Figure 1. Visual acuity gained in Snellen lines
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low preoperative corneal thickness as well as young 
age. It is also a good option for patients who have 
some irregularity in the preoperative topography, 
without topographic signs of keratoconus. This pro-
cedure provides keratometric and refractive stability. 
Postoperative visual acuity can be even better than 
BCVA, as shown in this study. This procedure also 
has the advantage of excluding all flap-related com-
plications that may occur in a LASIK procedure.
It is well documented [7–9] that ectasia after 
refractive surgery can occur. As noted earlier, there 
are some precautions [10, 11] that ophthalmologists 
should consider in order to avoid any unpleasant 
outcomes. It is well known and established [12, 13] 
that collagen crosslinking increases corneal stromal 
rigidity in keratoconic patients. There are also pre-
vious reports that combining collagen crosslinking 
with refractive surgery can enhance corneal stromal 
rigidity up to 130% [13].
Until now, many papers have been published 
regarding LASIK surgery combined with CXL. The 
reason is that LASIK surgery weakens the cornea 
[14, 15] much more than PRK, due to penetration 
into deeper corneal layers. 
Nowadays LASIK tends to be the most popular 
refractive surgery because of the fast visual reha-
bilitation and low postoperative pain. However, as 
already mentioned, not all patients are good LASIK 
candidates. In such cases one can proceed with PRK 
combined with CXL. Photorefractive Keratectomy 
combined with collagen crosslinking is preferred 
for younger patients with low preoperative corneal 
thickness [16] and/or abnormal preoperative to-
pography.
Our study is the first investigating the stability 
and efficacy of PRK combined with CXL (Fig. 2). 
It should also be noted that none of the patients 
was presented with corneal haze after surgery. We 
attribute that to the fact that due to CXL there was 
apoptosis of keratocytes from the anterior stroma. 
Because of the apoptosis, keratocytes did not pro-
duce the extracellular substance that is responsible 
for the development of corneal haze.
The instillation of riboflavin is done after the 
photo-ablation of the corneal epithelium and Bow-
man’s membrane. As a result, the diffusion of ri-
boflavin into the corneal stroma is faster, which is 
why the soak time of riboflavin is only 90 seconds, 
which is enough to achieve corneal crosslinking 
in comparison with the keratoconus treatment 
protocol, which requires 10 minutes of soak time. 
What should also be mentioned is that Vibex Xtra 
is quickly diffused due to its low viscosity. It is 
mentioned in the literature [17] that high fluence 
UVA is completely safe, since what should be taken 
into consideration is the product of energy with 
exposure time. 
It should be mentioned that none of the pa-
tients in our study developed severe dry eye after 
the surgery, even though there are studies [18] that 
indicate abnormal corneal innervation and dry eye 
after collagen crosslinking.
In some keratoconus patients that have under-
gone crosslinking in order to stabilise the progres-
sion of the disease, it has been observed that after 
months, or even years postoperatively their cor-
nea tends to flatten progressively. However, in our 
study at the end of the follow up period, we did 
not observe long-term topographic changes of the 
cornea, apart from those induced by laser abla-
tion. We believe that this observation is due to the 
fact that a different treatment protocol is used in 
keratoconus patients than the one we used in our 
patients. The total amount of energy used in PRK 
XTRA is 2.7 J/cm2, which is almost half the energy 
used to treat keratoconus patients. Since there were 
not any refractive surprises in our study, we believe 
that there is no need for nomogram alteration.
Our results show that PRK&CXL should be 
considered as a weapon in the ophthalmologist’s 
armoury in order to avoid iatrogenic ectasia. 
It is worth mentioning that the risk factors that 
lead to postoperative ectasia are yet to be fully un-
derstood. In the publication by Hodge et al. [19], 
a patient who had LASIK surgery in one eye and 
PRK in the other, who did not have risk for ectasia 
and scored low on Randleman’s risk factor score, 
developed postoperative ectasia in the eye that un-
derwent LASIK. Although we should consider the 
fact that there is only one patient who developed 
that kind of ectasia, there is an underlying question 
about the indications we take into consideration in 
order to decide which surgery is more suitable for 
each patient.
Figure 2. Demarcation line after PRK XtRA
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Another issue that should be investigated in 
the future is whether we could treat > 10 dioptres 
with PRK&CXL, since the risk of corneal haze and 
iatrogenic ectasia is significantly minimised with 
PRK XTRA.
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